GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis.

Glucose-dependent insulinotropic polypeptide (GIP) is a gastrointestinal hormone that potentiates glucose-stimulated insulin secretion during a meal. Since GIP has also been shown to exert β-cell prosurvival and adipocyte lipogenic effects in rodents, both GIP receptor agonists and antagonists have...

Full description

Bibliographic Details
Main Authors: Su-Jin Kim, Cuilan Nian, Subashini Karunakaran, Susanne M Clee, Carlos M Isales, Christopher H S McIntosh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3388996?pdf=render
_version_ 1811221768450342912
author Su-Jin Kim
Cuilan Nian
Subashini Karunakaran
Susanne M Clee
Carlos M Isales
Christopher H S McIntosh
author_facet Su-Jin Kim
Cuilan Nian
Subashini Karunakaran
Susanne M Clee
Carlos M Isales
Christopher H S McIntosh
author_sort Su-Jin Kim
collection DOAJ
description Glucose-dependent insulinotropic polypeptide (GIP) is a gastrointestinal hormone that potentiates glucose-stimulated insulin secretion during a meal. Since GIP has also been shown to exert β-cell prosurvival and adipocyte lipogenic effects in rodents, both GIP receptor agonists and antagonists have been considered as potential therapeutics in type 2 diabetes (T2DM). In the present study, we tested the hypothesis that chronically elevating GIP levels in a transgenic (Tg) mouse model would increase adipose tissue expansion and exert beneficial effects on glucose homeostasis. In contrast, although GIP Tg mice demonstrated enhanced β-cell function, resulting in improved glucose tolerance and insulin sensitivity, they exhibited reduced diet-induced obesity. Adipose tissue macrophage infiltration and hepatic steatosis were both greatly reduced, and a number of genes involved in lipid metabolism/inflammatory signaling pathways were found to be down-regulated. Reduced adiposity in GIP Tg mice was associated with decreased energy intake, involving overexpression of hypothalamic GIP. Together, these studies suggest that, in the context of over-nutrition, transgenic GIP overexpression has the potential to improve hepatic and adipocyte function as well as glucose homeostasis.
first_indexed 2024-04-12T08:06:07Z
format Article
id doaj.art-d81c14c65d904b4e959668416981da14
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T08:06:07Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d81c14c65d904b4e959668416981da142022-12-22T03:41:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0177e4015610.1371/journal.pone.0040156GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis.Su-Jin KimCuilan NianSubashini KarunakaranSusanne M CleeCarlos M IsalesChristopher H S McIntoshGlucose-dependent insulinotropic polypeptide (GIP) is a gastrointestinal hormone that potentiates glucose-stimulated insulin secretion during a meal. Since GIP has also been shown to exert β-cell prosurvival and adipocyte lipogenic effects in rodents, both GIP receptor agonists and antagonists have been considered as potential therapeutics in type 2 diabetes (T2DM). In the present study, we tested the hypothesis that chronically elevating GIP levels in a transgenic (Tg) mouse model would increase adipose tissue expansion and exert beneficial effects on glucose homeostasis. In contrast, although GIP Tg mice demonstrated enhanced β-cell function, resulting in improved glucose tolerance and insulin sensitivity, they exhibited reduced diet-induced obesity. Adipose tissue macrophage infiltration and hepatic steatosis were both greatly reduced, and a number of genes involved in lipid metabolism/inflammatory signaling pathways were found to be down-regulated. Reduced adiposity in GIP Tg mice was associated with decreased energy intake, involving overexpression of hypothalamic GIP. Together, these studies suggest that, in the context of over-nutrition, transgenic GIP overexpression has the potential to improve hepatic and adipocyte function as well as glucose homeostasis.http://europepmc.org/articles/PMC3388996?pdf=render
spellingShingle Su-Jin Kim
Cuilan Nian
Subashini Karunakaran
Susanne M Clee
Carlos M Isales
Christopher H S McIntosh
GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis.
PLoS ONE
title GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis.
title_full GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis.
title_fullStr GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis.
title_full_unstemmed GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis.
title_short GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis.
title_sort gip overexpressing mice demonstrate reduced diet induced obesity and steatosis and improved glucose homeostasis
url http://europepmc.org/articles/PMC3388996?pdf=render
work_keys_str_mv AT sujinkim gipoverexpressingmicedemonstratereduceddietinducedobesityandsteatosisandimprovedglucosehomeostasis
AT cuilannian gipoverexpressingmicedemonstratereduceddietinducedobesityandsteatosisandimprovedglucosehomeostasis
AT subashinikarunakaran gipoverexpressingmicedemonstratereduceddietinducedobesityandsteatosisandimprovedglucosehomeostasis
AT susannemclee gipoverexpressingmicedemonstratereduceddietinducedobesityandsteatosisandimprovedglucosehomeostasis
AT carlosmisales gipoverexpressingmicedemonstratereduceddietinducedobesityandsteatosisandimprovedglucosehomeostasis
AT christopherhsmcintosh gipoverexpressingmicedemonstratereduceddietinducedobesityandsteatosisandimprovedglucosehomeostasis